The widespread dissemination of robot-assisted radical prostatectomy (RARP) occurred despite the absence of high-level evidence supporting its safety and efficacy in patients with clinically localized prostate cancer. This study aims at systematically evaluating the models adopted in scientific reports assessing the comparative effectiveness of RARP versus open radical prostatectomy (ORP). Although several retrospective observational studies have assessed the comparative effectiveness of RARP and ORP, currently no published randomized data are available to comprehensively evaluate this issue. Furthermore, well-designed prospective investigations are needed to ultimately assess the benefits of RARP compared with other treatment modalities in patients with clinically localized prostate cancer.
Models of Assessment of Comparative Outcomes of Robot-Assisted Surgery Best Evidence Regarding the Superiority or Inferiority of Robot-Assisted Radical Prostatectomy / Gandaglia, G; Trinh, Qd. - In: UROLOGIC CLINICS OF NORTH AMERICA. - ISSN 0094-0143. - 41:4(2014), pp. 597-+. [10.1016/j.ucl.2014.07.014]
Models of Assessment of Comparative Outcomes of Robot-Assisted Surgery Best Evidence Regarding the Superiority or Inferiority of Robot-Assisted Radical Prostatectomy
Gandaglia G;
2014-01-01
Abstract
The widespread dissemination of robot-assisted radical prostatectomy (RARP) occurred despite the absence of high-level evidence supporting its safety and efficacy in patients with clinically localized prostate cancer. This study aims at systematically evaluating the models adopted in scientific reports assessing the comparative effectiveness of RARP versus open radical prostatectomy (ORP). Although several retrospective observational studies have assessed the comparative effectiveness of RARP and ORP, currently no published randomized data are available to comprehensively evaluate this issue. Furthermore, well-designed prospective investigations are needed to ultimately assess the benefits of RARP compared with other treatment modalities in patients with clinically localized prostate cancer.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
